Christopher L. McClendon

Molecular Biology · 2007

A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 7 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 19 citations into it; #5,352 of 17,773 by trust here, #7,911 by citations

Whom Christopher L. McClendon trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Sarah A. Teichmann
2. Christopher A. Lipinski

Who trusts Christopher L. McClendon overall

1. Andrea L. Jochim
2. Ji Luo
3. David K. Johnson
4. Paramjit S. Arora

Papers from Christopher L. McClendon's perspective

Ordered by how strongly the researchers Christopher L. McClendon trusts endorse each paper. Same corpus, a different order for every researcher.

1. The druggable genome (Nature reviews. Drug discovery)
2. Relating protein pharmacology by ligand chemistry
3. In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 (Science)
4. Drug-like properties and the causes of poor solubility and poor permeability. (Journal of pharmacological and toxicological methods)
5. Principles of protein-protein interactions (European Conference on Computational Biology)
6. Phage display for selection of novel binding peptides.
7. Structure-based maximal affinity model predicts small-molecule druggability (Nature Biotechnology)
8. Convergent solutions to binding at a protein-protein interface. (Science)
9. Basic local alignment search tool.
10. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Their papers

• Reaching for high-hanging fruit in drug discovery at protein–protein interfaces (2007) — 1,849 citations